Immuneering Corp. (IMRX)
4.43
+0.30
(+7.13%)
USD |
NASDAQ |
Jan 14, 16:00
4.44
+0.01
(+0.23%)
After-Hours: 20:00
Immuneering EPS Diluted (Quarterly): -0.3772 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Verastem, Inc. | -1.347 |
| Fortress Biotech, Inc. | 0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.96M |
| Total Expenses (Quarterly) | 14.96M |
| Enterprise Value | 62.40M |
| Earnings Yield | -40.25% |
| Normalized Earnings Yield | -40.25 |